X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (250) 250
Patent (56) 56
Publication (30) 30
Book Review (20) 20
Conference Proceeding (15) 15
Book Chapter (8) 8
Book / eBook (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (152) 152
humans (150) 150
hematology (107) 107
transplantation (102) 102
child (95) 95
child, preschool (88) 88
female (87) 87
male (86) 86
infant (78) 78
children (64) 64
abridged index medicus (63) 63
adolescent (62) 62
bone-marrow-transplantation (62) 62
treatment outcome (57) 57
hematopoietic stem cell transplantation (53) 53
immunology (53) 53
building (50) 50
finishing work on buildings, e.g. stairs, floors (50) 50
fixed constructions (50) 50
stem cells (48) 48
hematopoietic stem cells (45) 45
retrospective studies (40) 40
pediatrics (35) 35
stem cell transplantation (33) 33
adult (32) 32
transplantation, homologous (31) 31
stem-cell transplantation (30) 30
bone marrow (29) 29
immunodeficiency (28) 28
transplantation conditioning - methods (28) 28
hematopoietic stem cell transplantation - adverse effects (27) 27
versus-host-disease (27) 27
hematopoietic stem cell transplantation - methods (26) 26
infant, newborn (24) 24
disease (22) 22
bone marrow transplantation (21) 21
immune reconstitution (21) 21
doors, windows, shutters, or roller blinds in general (20) 20
fixed or movable closures for openings in buildings, vehicles,fences or like enclosures in general, e.g. doors, windows,blinds, gates (20) 20
follow-up studies (20) 20
ladders (20) 20
lymphocytes (20) 20
severe combined immunodeficiency - therapy (20) 20
survival (20) 20
survival analysis (20) 20
t-lymphocytes - immunology (20) 20
transplantation conditioning (20) 20
graft vs host disease - etiology (19) 19
t cells (19) 19
blood (18) 18
hematology, oncology and palliative medicine (18) 18
mortality (18) 18
transplants & implants (18) 18
article (17) 17
care and treatment (17) 17
health aspects (17) 17
severe combined immunodeficiency (17) 17
analysis (16) 16
disease-free survival (16) 16
mutations (16) 16
immunologic deficiency syndromes - therapy (15) 15
middle aged (15) 15
risk factors (15) 15
young adult (15) 15
children's hospitals (14) 14
graft vs host disease - prevention & control (14) 14
mutation (14) 14
oncology (14) 14
therapy (14) 14
unrelated donors (14) 14
allergy (13) 13
bone-marrow (13) 13
europe (13) 13
leukemia (13) 13
recipients (13) 13
cancer (12) 12
experience (12) 12
primary immunodeficiency (12) 12
rheumatology (12) 12
severe combined immunodeficiency - immunology (12) 12
survival rate (12) 12
time factors (12) 12
allergy and immunology (11) 11
chimerism (11) 11
diseases (11) 11
alemtuzumab (10) 10
chemotherapy (10) 10
cord blood transplantation (10) 10
patients (10) 10
reconstitution (10) 10
recurrence (10) 10
severe combined immunodeficiency - mortality (10) 10
acute lymphoblastic-leukemia (9) 9
blasting (9) 9
busulfan (9) 9
chronic granulomatous-disease (9) 9
conditioning (9) 9
cord blood (9) 9
graft vs host disease - epidemiology (9) 9
heating (9) 9
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (294) 294
French (35) 35
German (29) 29
Dutch (17) 17
Spanish (4) 4
Croatian (1) 1
Polish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9915, pp. 436 - 448
Summary Background In chronic granulomatous disease allogeneic haemopoietic stem-cell transplantation (HSCT) in adolescents and young adults and patients with... 
Internal Medicine | NADPH OXIDASE | MEDICINE, GENERAL & INTERNAL | EXCELLENT SURVIVAL | IN-VITRO | UNRELATED DONOR | BONE-MARROW-TRANSPLANTATION | EUROPEAN EXPERIENCE | INTRAVENOUS BUSULFAN | RECONSTITUTION | NONMALIGNANT DISEASES | CHILDREN | Transplantation Chimera - physiology | Prospective Studies | Humans | Child, Preschool | Infant | Treatment Outcome | Granulomatous Disease, Chronic - therapy | Vidarabine - analogs & derivatives | Alemtuzumab | Antilymphocyte Serum - administration & dosage | Busulfan - administration & dosage | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Adolescent | Adult | Graft vs Host Disease - prevention & control | Vidarabine - administration & dosage | HLA Antigens | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Drug Therapy, Combination | Graft Survival - drug effects | Child | Immunosuppressive Agents - administration & dosage | Granuloma | Care and treatment | Histocompatibility antigens | Patient outcomes | HLA histocompatibility antigens | Stem cells | Transplantation | Identification and classification | Bone marrow | Teenagers | Transplants & implants | Mortality | Index Medicus | Abridged Index Medicus | Pediatrics | Immunologi inom det medicinska området | Pediatrik | hematopoietisk stamcellstransplantation | chronic granulomatous disease | Immunology in the medical area
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9693, pp. 912 - 920
Summary Background Stem-cell transplantation can cure primary immunodeficiencies. However, in patients with pre-existing organ toxicity, patients younger than... 
Internal Medicine | TOTAL-BODY IRRADIATION | REDUCED-INTENSITY | MEDICINE, GENERAL & INTERNAL | SEVERE COMBINED IMMUNODEFICIENCY | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | DYSKERATOSIS-CONGENITA | DNA-LIGASE IV | ACUTE MYELOID-LEUKEMIA | MONOCLONAL-ANTIBODIES | NONMALIGNANT DISEASES | Antibodies, Neoplasm - therapeutic use | Graft vs Host Disease - epidemiology | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Infant | Male | Cyclophosphamide - therapeutic use | Transplantation Conditioning - mortality | Antibodies, Monoclonal, Humanized | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Graft vs Host Disease - etiology | Immunologic Deficiency Syndromes - therapy | Kaplan-Meier Estimate | Rats | Treatment Outcome | Vidarabine - analogs & derivatives | Alemtuzumab | Vidarabine - therapeutic use | Transplantation Chimera | Leukocyte Common Antigens - antagonists & inhibitors | Disease-Free Survival | Animals | Graft vs Host Disease - prevention & control | Hematopoietic Stem Cell Transplantation - methods | Immunologic Factors - therapeutic use | Care and treatment | Usage | Patient outcomes | Immunodeficiency | Stem cells | Transplantation | Children | Health aspects | Diseases | Bone marrow | Medical research | Transplants & implants | Mortality | Metabolic disorders | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 126, Issue 3, pp. 602 - 610.e11
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 133, Issue 2, pp. 335 - 347.e11
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 11, pp. 1863 - 1869
Journal Article
by Boelens, Jaap Jan and Boelens, Jaap Jan and Aldenhoven, Mieke and Aldenhoven, Mieke and Purtill, Duncan and Purtill, Duncan and Ruggeri, Annalisa and Ruggeri, Annalisa and Defor, Todd and DeFor, Todd and Wynn, Robert and Wynn, Robert and Wraith, E and Wraith, Ed and Cavazzana-Calvo, Marina and Cavazzana-Calvo, Marina and Rovelli, Attilio and Rovelli, Attilio and Fischer, Alain and Fischer, Alain and Tolar, Jakub and Tolar, Jakub and Prasad, Vinod K and Prasad, Vinod K and Escolar, Maria and Escolar, Maria and Gluckman, Eliane and Gluckman, Eliane and O'Meara, Anne and O’Meara, Anne and Orchard, Paul J and Orchard, Paul J and Veys, Paul and Veys, Paul and Eapen, Mary and Eapen, Mary and Kurtzberg, Joanne and Kurtzberg, Joanne and Rocha, Vanderson and Rocha, Vanderson and Eurocord, Eurocord and Malech, H and Horwitz, E and Inborn Errors Working Party of European Blood and Marrow Transplant group, Errors Working Party of European Blood and Marrow Transplant group and Le-Rademacher, J and Duke University Blood and Marrow Transplantation Program, University Blood and Marrow Transplantation Program and He, W and Centre for International Blood and Marrow Research, for International Blood and Marrow Research and Gaspar, B and Porta, F and Driscoll, T.A and Landi, D.B and Martin, P.L and Page, K.M and Parikh, H and Ctr Int Blood Marrow Res and Duke Univ and Inborn Errors Working Party of European Blood and Marrow Transplant group and Duke University Blood and Marrow Transplantation Program and Eurocord and Centre for International Blood and Marrow Research and on behalf of all participating centers from Eurocord, Inborn Errors Working Party of European Blood and Marrow Transplant group, Duke University, and the Centre for International Blood and Marrow Research
Blood, ISSN 0006-4971, 05/2013, Volume 121, Issue 19, pp. 3981 - 3987
Journal Article
Pediatrics, ISSN 0031-4005, 03/2009, Volume 123, Issue 3, pp. 836 - 840
Journal Article
Pediatric Reports, ISSN 2036-749X, 2011, Volume 3, Issue 2S, pp. 28 - 31
Studies so far indicate that reduced intensity transplantation (RIT) may have an important role in treating patients with primary immunodeficiency disease... 
Reduced intensity transplantation | Immunodeficiency disorders
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2014, Volume 134, Issue 4, pp. 935 - 943.e15
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 138, Issue 3, pp. 852 - 859.e3
Journal Article